PPARG and renal carcinoma: Peroxisome proliferator-activated receptor gamma (PPARG) could induce cell cycle arrest, terminal differential, and anti-inflammatory [72,73], and induce G2/M cell cycle arrest by activating P38 in renal cancer and bladder cancer [74,75].